| P50 | author | Christine E. Staatz | Q37840730 |
| | Stefanie Hennig | Q42810852 |
| P2093 | author name string | C C Llanos-Paez | |
| P2860 | cites work | Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. | Q51997391 |
| | A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. | Q52016990 |
| | Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. | Q52071390 |
| | Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. | Q54319060 |
| | Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy | Q33606479 |
| | Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury | Q34108507 |
| | Renal transport of antibiotics and nephrotoxicity: a review | Q34472677 |
| | Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates | Q34570930 |
| | Measured GFR as a confirmatory test for estimated GFR. | Q34659317 |
| | Aminoglycoside nephrotoxicity: modeling, simulation, and control | Q34735262 |
| | Risk factors for toxicity in elderly patients given aminoglycosides once daily. | Q34752229 |
| | Population pharmacokinetics of gentamicin and dosing optimization for infants | Q34923469 |
| | Gentamicin blood levels: a guide to nephrotoxicity | Q34934750 |
| | Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis | Q35001792 |
| | Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii | Q35168931 |
| | Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients | Q35191383 |
| | Pharmacodynamics and dosing of aminoglycosides | Q35623060 |
| | Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC | Q35637864 |
| | Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans | Q35642347 |
| | Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates | Q35755665 |
| | Population pharmacokinetics of gentamicin in patients with cancer | Q35802610 |
| | Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies | Q35821763 |
| | Population pharmacokinetics of intramuscular gentamicin administered to young infants with suspected severe sepsis in Kenya | Q35825593 |
| | Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. | Q35826231 |
| | The effect of sepsis upon gentamicin pharmacokinetics in neonates. | Q35827298 |
| | Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery. | Q35827409 |
| | Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. | Q36053463 |
| | Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice | Q36075844 |
| | Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration | Q36568925 |
| | Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia | Q36924742 |
| | Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development | Q36949430 |
| | Mechanism-based concepts of size and maturity in pharmacokinetics | Q36960112 |
| | Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia | Q36980151 |
| | Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants | Q37120041 |
| | Suboptimal aminoglycoside dosing in critically ill patients | Q37341556 |
| | Application of pharmacokinetic-pharmacodynamic modeling and the justification of a novel fusidic acid dosing regimen: raising Lazarus from the dead. | Q37872519 |
| | A pharmacokinetic standard for babies and adults | Q38104694 |
| | Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs | Q38117228 |
| | Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization | Q38626980 |
| | Challenges in ototoxicity monitoring in the pediatric oncology population. | Q39101306 |
| | Once versus thrice daily gentamicin in patients with serious infections | Q39369365 |
| | Population Pharmacokinetics of Gentamicin in Mexican Children With Severe Malnutrition | Q39598358 |
| | Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II). | Q39654030 |
| | Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 |
| | Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition | Q40235780 |
| | Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants | Q40326667 |
| | Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen | Q40794081 |
| | The post-antibiotic effect | Q40804547 |
| | Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model | Q40857961 |
| | Single or multiple daily doses of aminoglycosides: a meta-analysis | Q42145555 |
| | Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia | Q42259839 |
| | Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa | Q42549535 |
| | Population pharmacokinetics of gentamicin in premature newborns. | Q42688816 |
| | Gentamicin in hemodialyzed critical care patients: early dialysis after administration of a high dose should be considered | Q42952777 |
| | Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study | Q43280018 |
| | Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients | Q43738821 |
| | Population pharmacokinetic study of gentamicin and a Bayesian approach in patients with renal impairment | Q44436929 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis | Q44570722 |
| | Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing | Q44911958 |
| | Human renal function maturation: a quantitative description using weight and postmenstrual age. | Q45281878 |
| | Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. | Q45984535 |
| | Pharmacodynamics of tobramycin in patients with cystic fibrosis | Q46554477 |
| | A size standard for pharmacokinetics. | Q47332170 |
| | Population pharmacokinetics of gentamicin in South African newborns | Q47435744 |
| | Quantification of lean bodyweight. | Q50753849 |
| | Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance. | Q51827302 |
| | Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. | Q51930719 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| | gentamicin | Q422482 |
| | pharmacodynamics | Q725307 |
| P304 | page(s) | 639-667 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy | |
| P478 | volume | 72 | |